Me pasan esta información que es interesante para los que tomamos mate. Los valores de cafeína son más bajos de lo que pensaba y de lo que se indica en páginas en internet.
* La infusión preparada con una cucharadita de Mate Cocido Instantáneo Taragüi aporta aproximadamente
0,002 grs. de cafeína.
* Yerba Mate en cebadura Taragüi: - 50 g en 500 ml -: entre 180 y 220 mg. aproximadamente
(esto teniendo en cuenta el porcentaje de palo, que no contiene cafeína, y
el porcentaje de extractabilidad desde la infusión (aprox. 65%)).
* Mate Cocido Unión: - 3 g en 200 ml -: 27 mg. aproximadamente (teniendo en
cuenta un 100% de extractabilidad).
Nootrópicos (smartdrugs, drogas inteligentes, potenciadores cognitivos) son sustancias artificiales (medicamentos como piracetam, hydergina, citicolina, fosfatidilserina, vinpocetina, etc.) o naturales (suplementos nutricionales, vitaminas, aminoácidos, hormonas, hierbas, etc. como vitaminas B, piroglutamato, Gingko Biloba, fenilalanina, DHEA, pregnenolona, etc.) que se utilizan para mejorar la capacidad cognitiva (memoria, atención, etc.) en personas con trastornos o normales.
jueves, noviembre 16, 2006
Relacion entre fumar y deficit de atencion
Los déficits de atención podrian ser motivantes del hábito de fumar y deberísn ser tenidos en cuenta al ahora de realizar tratamientos para dejar de fumar.
Columbia Study Examines ADHD’s Role in Smoking
New York Are you easily forgetful, distracted, impulsive or fidgety? Do you find that smoking helps you alleviate these symptoms?
Columbia University Medical Center researchers are investigating whether these most common symptoms of attention deficit hyperactivity disorders (ADHD) could be causing people to smoke. If that is the case, will treatment for ADHD combined with the standard treatment to help people quit smoking the patch with counseling increase the quit rates for smokers trying to quit?
Covey and her colleagues are recruiting smokers who have been diagnosed with ADHD or who may have symptoms of ADHD but have not yet been diagnosed, to be part of a study that will help them quit smoking. Approximately 7-8 million adults in the U.S. have ADHD. Smoking is twice as common in this population as in the general population.
Research has shown that most smoking in the U.S. occurs among people who have psychiatric conditions, such as alcohol or drug abuse, major depression, anxiety and ADHD. One line of research has shown that smokers with these conditions “self-medicate” their symptoms with nicotine, the primary addictive substance in tobacco.
Participants in the study will receive the nicotine patch, behavioral counseling, and a drug approved by the Food and Drug Administration for the treatment of ADHD called methylphenidate (brand name CONCERTA®). Because methylphenidate and nicotine act on the brain in a similar way, the premise is that treatment with methylphenidate when trying to quit smoking may reduce symptoms of ADHD while also reducing tobacco withdrawal symptoms.
Columbia Study Examines ADHD’s Role in Smoking
New York Are you easily forgetful, distracted, impulsive or fidgety? Do you find that smoking helps you alleviate these symptoms?
Columbia University Medical Center researchers are investigating whether these most common symptoms of attention deficit hyperactivity disorders (ADHD) could be causing people to smoke. If that is the case, will treatment for ADHD combined with the standard treatment to help people quit smoking the patch with counseling increase the quit rates for smokers trying to quit?
Covey and her colleagues are recruiting smokers who have been diagnosed with ADHD or who may have symptoms of ADHD but have not yet been diagnosed, to be part of a study that will help them quit smoking. Approximately 7-8 million adults in the U.S. have ADHD. Smoking is twice as common in this population as in the general population.
Research has shown that most smoking in the U.S. occurs among people who have psychiatric conditions, such as alcohol or drug abuse, major depression, anxiety and ADHD. One line of research has shown that smokers with these conditions “self-medicate” their symptoms with nicotine, the primary addictive substance in tobacco.
Participants in the study will receive the nicotine patch, behavioral counseling, and a drug approved by the Food and Drug Administration for the treatment of ADHD called methylphenidate (brand name CONCERTA®). Because methylphenidate and nicotine act on the brain in a similar way, the premise is that treatment with methylphenidate when trying to quit smoking may reduce symptoms of ADHD while also reducing tobacco withdrawal symptoms.
Suscribirse a:
Entradas (Atom)